Qing Song Health Co.,Ltd. (6931) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Qing Song Health Co.,Ltd. TWD 21.01, price TWD 38.75, upside -45.8%, quality 38 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Qing Song Health Co.,Ltd. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
45‑month range 32.04 TWD – 107.84 TWD · fair‑value band 12.84 TWD – 29.46 TWD · the 38.75 TWD price screens above the 21.01 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Qing Song Health Co. in your weekly email
Every Wednesday you see whether Qing Song Health Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Qing Song Health Co.,Ltd. provides long-term care services in Taiwan. It offers community-based and residential long-term care services, providing home, and community to residential and other diversified care. The company was founded in 1996 and is based in Taichung, Taiwan.
Stock analysis
Qing Song Health Co.,Ltd. (6931) currently trades at 38.75 TWD, while our model-based Fair Value estimate is 21.01 TWD, implying the stock looks roughly 84.4% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 61.24 TWD per share, and 4 of the 17 models we run sit above the 38.75 TWD price.
Bear case: the Dividend Discount group reads lowest at 6.64 TWD, and 13 of the 17 models stay below the price. Evidence for this calculation is high.
Scenario range: 12.84 TWD (bear) to 29.46 TWD (bull), the price of 38.75 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Qing Song Health Co.,Ltd. reported revenue of 1.1B TWD in FY2025 versus 358M TWD in FY2021, a compound +33.1%/yr. Reported net income was 91.7M TWD in FY2025.
Key figures
Market cap 2.6B TWD (≈ $80.7M) · P/E ratio 10.3 · P/S ratio 0.84 · EPS (TTM) 3.77 TWD · Dividend yield 0.3% · Net margin 8.2% · Return on equity 21.3% · Return on assets (EBIT) 1.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 43% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −46%, 6931 screens richer than that median.
Fair Value models
Bear 12.84 TWDFair Value 21.01 TWDBull 29.46 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (2.68 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+14.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.8%
’21
’22
’23
’24
’25
What shareholders gained per year (last 3 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ +16.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+15.7%
Dividend (yield on the price)0.3%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−1% → 5%
⚠ Rate on operating basis: 2025 sits 105% above its own trend.
Compare Qing Song Health Co.,Ltd. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 258 stocks
Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score38 · Bottom 25%
Fair Value upside−46% · Bottom 25%
Profitability
Return on equity (TTM)21% · Top 25%
Return on assets2% · Below median
Net margin (TTM)21% · Top 25%
Operating margin (TTM)7% · Below median
Growth and dividend
Revenue growth15% · Above median
Dividend yield (TTM)0.3% · Bottom 25%
Balance sheet
Debt / equity0.12× · Below median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (TTM)10.3× · Cheapest 25%
P/B2.24× · Pricier than median
P/S (TTM)2.12× · Priciest 25%
EV/EBITDA14.9× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)77· sector 28
PAST (return on equity)85· sector 31
HEALTH (low debt)94· sector 89
DIVIDEND (yield)6· sector 43
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Qing Song Health Co.,Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/6931
Frequently asked questions
Is Qing Song Health Co.,Ltd. (6931) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 21.01 TWD versus a price of 38.75 TWD, about −46% upside (overvalued).
What is the fair value of 6931?
Our model-based fair value for Qing Song Health Co.,Ltd. is 21.01 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 38.75 TWD.
What is the quality score of 6931?
Qing Song Health Co.,Ltd. has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Qing Song Health Co.,Ltd. (6931)?
Our model-based price target is the fair value of 21.01 TWD (as of Sep 24, 2026) from 17 valuation models. Cautious scenario 12.84 TWD, optimistic scenario 29.46 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Qing Song Health Co.,Ltd. stock forecast for 2026?
Our models put fair value at 21.01 TWD, about −46% upside versus a price of 38.75 TWD (overvalued). Cautious scenario 12.84 TWD, optimistic scenario 29.46 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Qing Song Health Co.,Ltd. (6931)?
Qing Song Health Co.,Ltd. reported trailing-twelve-month revenue of about 1.2B TWD (latest available figure, as of Sep 24, 2026).
Does Qing Song Health Co.,Ltd. pay a dividend?
Qing Song Health Co.,Ltd. currently shows a dividend yield of about 0.31% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Qing Song Health Co.,Ltd. (6931)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Qing Song Health Co.,Ltd. it is 21.01 TWD per share (as of Sep 24, 2026), against a price of 38.75 TWD. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Qing Song Health Co.,Ltd. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 6931 trades above its calculated fair value: price 38.75 TWD, fair value 21.01 TWD, a gap of about −46% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6931?
No. The price is what the market pays today (38.75 TWD); the fair value is what the company's own numbers justify (21.01 TWD). For Qing Song Health Co.,Ltd. the two are 17.74 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Qing Song Health Co.,Ltd. worth?
The market values Qing Song Health Co.,Ltd. at about 2.6B TWD (market capitalisation, as of Sep 24, 2026). Per share that is 38.75 TWD; our models calculate a fair value of 21.01 TWD per share.
What do the bullish and bearish scenarios say about 6931?
Our models span a range for Qing Song Health Co.,Ltd.: cautious scenario 12.84 TWD, base 21.01 TWD, optimistic 29.46 TWD per share (as of Sep 24, 2026, price 38.75 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6931?
Qing Song Health Co.,Ltd. trades at a price-to-earnings ratio of 10.3 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 21.01 TWD is built from several models across several years. Other multiples: P/B 2.2, P/S 2.1, EV/EBITDA 14.9.
How solid is the balance sheet of Qing Song Health Co.,Ltd. (6931)?
Balance-sheet figures for Qing Song Health Co.,Ltd. (as of Sep 24, 2026): return on equity 21.3%, debt of 0.12 per unit of equity. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is 6931 from its 52-week high?
Qing Song Health Co.,Ltd. trades at 38.75 TWD, about 43% below its 52-week high of 67.64 TWD and 7% above the low of 36.20 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 21.01 TWD is for.
Which stocks are comparable to Qing Song Health Co.,Ltd.?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Qing Song Health Co.,Ltd. stock attractive at the current price?
The data as of Sep 24, 2026: price 38.75 TWD, calculated fair value 21.01 TWD (−46%), Quality Score 38/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6931 calculated?
We run Qing Song Health Co.,Ltd. through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 21.01 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Qing Song Health Co.,Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Qing Song Health Co.,Ltd. (6931)?
The closing price on Sep 24, 2026 was 38.75 TWD. Our model-based fair value is 21.01 TWD, about −46% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Qing Song Health Co.,Ltd. right now?
The price sits above even our optimistic bull case (29.46 TWD). The favourable scenario is already priced in. Weak quality (38/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range (12.84 TWD to 29.46 TWD) leaves room in how you read the outcome.
Key figures of Qing Song Health Co.,Ltd.
How large is the market capitalisation of Qing Song Health Co.,Ltd. (6931)?
The market capitalisation of Qing Song Health Co.,Ltd. is 2.6B TWD (≈ $80.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Qing Song Health Co.,Ltd. (6931)?
The price-to-sales ratio of Qing Song Health Co.,Ltd. is 0.84 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Qing Song Health Co.,Ltd. (6931)?
Earnings per share at Qing Song Health Co.,Ltd. are 3.77 TWD (price ÷ EPS = P/E 10.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Qing Song Health Co.,Ltd. (6931)?
The dividend yield of Qing Song Health Co.,Ltd. is 0.3% (payout 3.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Qing Song Health Co.,Ltd. (6931)?
The net margin of Qing Song Health Co.,Ltd. is 8.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Qing Song Health Co.,Ltd. (6931)?
The return on equity (ROE) of Qing Song Health Co.,Ltd. is 21.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Qing Song Health Co.,Ltd. (6931)?
On an EBIT basis the return on assets of Qing Song Health Co.,Ltd. is 1.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Qing Song Health Co.,Ltd. (6931)?
The operating margin of Qing Song Health Co.,Ltd. is 7.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Qing Song Health Co.,Ltd. (6931)?
Revenue at Qing Song Health Co.,Ltd. is growing +15.4% versus a year earlier (3y avg +20.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Qing Song Health Co.,Ltd. (6931)?
Earnings per share at Qing Song Health Co.,Ltd. are growing +508% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Qing Song Health Co.,Ltd. (6931) generate?
The free cash flow of Qing Song Health Co.,Ltd. is −152M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Qing Song Health Co.,Ltd. in the live analysis
One click puts Qing Song Health Co.,Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
